Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M307Revenue $M20.6Net Margin (%)-99.5Z-Score3.7
Enterprise Value $M251EPS $-0.2Operating Margin %-101.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-100.9Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %-8.7Quick Ratio2.8Cash flow > EarningsY
Price/Sales13.85-y EBITDA Growth Rate %8.0Current Ratio3.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-23.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)5ROE % (ttm)-29.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M130ROI % (ttm)-30.0Gross Margin Increase y-yY

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSJean-Marie Eveillard 2012-06-30 Sold Out $2.63 - $3.3
($3.04)
$ 2.35-23%Sold Out0
ATRSJean-Marie Eveillard 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 2.3542%New holding, 20000 sh.20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ATRS Jean-Marie Eveillard 2014-06-3020,0000.020
Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROCHE ROBERT P JRDirector 2014-08-13Buy5,000$1.9619.9view
GUETH ANTONDirector 2014-08-11Buy5,000$217.5view
GARRITY THOMAS JDirector 2014-08-11Buy5,000$1.9818.69view
SAMSON MARVINDirector 2014-08-11Buy25,000$217.5view
JACOB LEONARD SDirector 2014-08-11Buy10,000$1.9818.69view
JACOB LEONARD SDirector 2014-01-15Sell11,400$5.05-53.47view
Wotton Paul KPresident and CEO 2014-01-15Sell22,900$5.1-53.92view
APPLE ROBERT FExecutive Vice President & CFO 2014-01-10Sell10,000$5-53view
Wotton Paul KPresident and CEO 2013-12-09Sell64,100$4-41.25view
APPLE ROBERT FExecutive Vice President & CFO 2013-10-14Sell22,000$5.05-53.47view

Press Releases about ATRS :

    Quarterly/Annual Reports about ATRS:

    News about ATRS:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

    More From Other Websites
    ANTARES PHARMA, INC. Financials Aug 15 2014
    Q2 2014 Antares Pharma, Inc. Earnings Release - Before Market Open Aug 07 2014
    ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Aug 07 2014
    Antares Pharma Reports Second Quarter 2014 Operating and Financial Results Aug 07 2014
    Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call Jul 31 2014
    ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 22 2014
    Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot Study Evaluating... Jul 22 2014
    ANTARES PHARMA, INC. Files SEC form 8-K, Other Events Jul 11 2014
    Antares: Uncertainty Creates An Exceptional Buying Opportunity Jul 08 2014
    Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved with Once-Weekly... Jun 25 2014
    Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% Jun 25 2014
    ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 24 2014
    Antares Pharma Announces Changes in Senior Leadership Jun 24 2014
    ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 04 2014
    Otrexup Sales Trajectory Points To First Profitable Quarter For Antares Pharma In 2015 May 28 2014
    Antares Pharma to Present at the Jefferies 2014 Global Healthcare Conference May 28 2014
    Antares Pharma Appoints Jennifer Evans Stacey, Esq., Senior Vice President, General Counsel, Human... May 22 2014
    Antares Pharma announces publication of three abstracts May 20 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK